TMEM176B and breast carcinoma: We found TMEM176B amplified in 6.5%, showing a copy number gain in 20.1% of basal-like breast cancers, which have significant cross-over with TNBC compared with other breast cancer subtypes in the METABRIC dataset (Supplementary Figure S1A).